Vaccines

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

There’s a lot going on in the world of biopharma but never fear because we’ve got you covered…

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

Though mRNA technologies are helping to expand the industry's horizons, there manufacture does come with challenges.

Applying mRNA technology to the treatment of malaria.

Could mRNA vaccine be the flu interventions of tomorrow?

We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

What milestones will define the next era in the mRNA story?